This document contains questions for a seasoned pharmaceutical professional regarding their current role and perspectives on key challenges and opportunities for the Indian pharmaceutical industry during the COVID-19 pandemic. The professional is asked about challenges facing the industry in India now, how companies can ensure business continuity given limited in-person access to doctors, important skills for customer-facing executives and brand/marketing managers going forward, and how the professional sees the Indian pharmaceutical industry shaping up after COVID-19.

2. C a n Y o u B r i e f l y T e l l U s A b o u t
Y o u r C u r r e n t R o l e ?
• Lead Consultant, Strategy, Solutions, Indegene Life Systems
• Head South Asia, Biocon Branded Formulations
• Sr. Director, Global Established Products, Pfizer Ltd
• Vice President, Primary Care, BD, Strategy AstraZeneca – India
& Thailand
• Marketing Manager, Novartis India Ltd

3. Q.1. As a seasoned pharma professional, with vast experience across both
MNC and domestic pharma, what do you see as the key challenges facing
pharma industry in India, now?

4. Q.2. Given the challenges of field force people in meeting doctors F2F,
what should be the focus of marketing and business heads in ensuring
business continuity and growth in these challenging times?

5. Q.3 What are some key skills that you consider as necessary in the present
times and going forward for: a) Customer facing executives
b) Brand and Marketing Managers.

6. Q.4. How do you see Indian Pharma shaping up in the aftermath of the
Covid1-19 crisis?